Andere Sprachen SOPHiA GENETICS SA

Aktien

A3CVT8

CH1125843347

SOPH

Verzögert Nasdaq Andere Börsenplätze 17:09:29 02.05.2024			% 5 Tage	% 1. Jan.
4,955 ^USD	-1,69 %		+0,10 %	+5,20 %

23.04.	SOPHiA GENETICS kündigt Syndicate Bio als ersten Kunden für Flüssigbiopsie in Afrika an	CI
17.04.	SOPHiA GENETICS gibt bekannt, dass Unilabs seine KI-Technologie zur Erkennung von Defiziten bei der homologen Rekombination nutzt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference	30.04.
SOPHiA GENETICS : to Present at the 2024 RBCCM Global Healthcare Conference	30.04.
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024	23.04.
Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering	23.04.
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa	23.04.
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa	23.04.
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)	17.04.
SOPHiA GENETICS Announces Unilabs Using Its AI Technology to Detect Homologous Recombination Deficiency	17.04.
Sophia Genetics Forms Partnership With Strand Life Sciences to Advance Diagnostic Tools	04.04.
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership	04.04.
Laboratorio Barnafi-Krause is Live on SOPHiA DDM™	02.04.
Sophia Genetics SA Announces Laboratorio Barnafi-Krause Is Live on the Sophia DDM? Platform	02.04.
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada	20.03.
SOPHiA GENETICS Announces First Homologous Recombination Deficiency Customer in Canada	20.03.
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration	15.03.
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference	07.03.
SOPHiA GENETICS : Announces New Customer in Costa Rica	07.03.
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results	05.03.
SOPHiA GENETICS SA Provides Earnings Guidance for 2024	05.03.
SOPHiA GENETICS SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	05.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen SOPHiA GENETICS SA

Aktien

A3CVT8

CH1125843347

SOPH

Andere Sprachen

Filter